PDS Biotech Reports Second Quarter 2022 Financial Results and Provides Business Update

Go back to PDS Biotech Reports Second Quarter 2022 Financial Results and Provides Business Update

PDS Biotechnology (PDSB) Tops Q2 EPS by 8c

August 8, 2022 7:11 AM EDT

PDS Biotechnology (NASDAQ: PDSB) reported Q2 EPS of ($0.20), $0.08 better than the analyst estimate of ($0.28).

For earnings history and earnings-related data on PDS Biotechnology (PDSB) click here.

... More